Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Neriman Gokden

Concepts (349)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
13
2021
174
2.600
 Why?
Carcinoma, Renal Cell
13
2021
101
2.260
 Why?
Kidney Diseases
8
2020
213
1.160
 Why?
Immunohistochemistry
14
2021
957
1.120
 Why?
PAX2 Transcription Factor
4
2010
22
1.050
 Why?
Kidney
14
2025
696
1.040
 Why?
Kidney Tubules
7
2021
61
1.020
 Why?
Immunoglobulin Light Chains
4
2017
84
0.790
 Why?
Neoplasms, Complex and Mixed
1
2020
2
0.710
 Why?
Rhabdoid Tumor
1
2020
12
0.700
 Why?
Stromal Cells
1
2020
75
0.680
 Why?
Soft Tissue Neoplasms
1
2020
54
0.660
 Why?
Acute Kidney Injury
8
2025
303
0.650
 Why?
Immune Complex Diseases
2
2008
6
0.580
 Why?
Sepsis
7
2014
225
0.540
 Why?
Mitogen-Activated Protein Kinases
2
2008
155
0.500
 Why?
Adenoma
2
2021
113
0.440
 Why?
Adenoma, Oxyphilic
2
2010
11
0.430
 Why?
Carcinoma, Papillary
2
2010
47
0.410
 Why?
Male
38
2025
25907
0.410
 Why?
Middle Aged
26
2025
12611
0.380
 Why?
Renal Circulation
5
2013
60
0.380
 Why?
Prostatic Neoplasms
5
2010
384
0.380
 Why?
Proteinuria
2
2010
37
0.360
 Why?
Humans
44
2025
50503
0.360
 Why?
Glomerulonephritis, IGA
1
2010
5
0.360
 Why?
Podocytes
1
2010
19
0.360
 Why?
Microcirculation
5
2014
72
0.350
 Why?
Nephrectomy
2
2010
81
0.340
 Why?
Antigens, Neoplasm
2
2008
148
0.340
 Why?
Microscopy, Electron, Transmission
5
2014
75
0.340
 Why?
Neurofibromatosis 2
1
2009
8
0.330
 Why?
DNA Glycosylases
1
2008
19
0.300
 Why?
Adult
19
2023
13577
0.300
 Why?
Lymph Nodes
1
2010
257
0.290
 Why?
Renal Insufficiency
4
2013
110
0.290
 Why?
Kidney Glomerulus
1
2008
37
0.290
 Why?
Plasmacytoma
2
2020
42
0.290
 Why?
Female
25
2025
27081
0.290
 Why?
DNA Repair
1
2008
188
0.280
 Why?
Hypercalcemia
1
2007
33
0.270
 Why?
Diagnosis, Differential
6
2021
1033
0.270
 Why?
Alphapapillomavirus
1
2006
13
0.270
 Why?
Sensitivity and Specificity
5
2011
859
0.270
 Why?
Predictive Value of Tests
6
2025
930
0.270
 Why?
Carcinoma
2
2020
137
0.260
 Why?
Bone Density Conservation Agents
1
2007
74
0.260
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
59
0.260
 Why?
Glomerulosclerosis, Focal Segmental
1
2006
13
0.260
 Why?
Urinary Bladder Neoplasms
3
2014
158
0.260
 Why?
Diphosphonates
1
2007
90
0.260
 Why?
Imidazoles
1
2007
127
0.260
 Why?
DNA, Viral
1
2006
136
0.260
 Why?
Hepatitis B
1
2006
23
0.260
 Why?
Prostatic Intraepithelial Neoplasia
2
2005
8
0.260
 Why?
Biopsy
6
2020
588
0.250
 Why?
Adenocarcinoma
2
2010
397
0.240
 Why?
Skin Neoplasms
2
2018
491
0.240
 Why?
Cisplatin
4
2025
286
0.240
 Why?
Insulin-Like Growth Factor Binding Protein 1
1
2025
15
0.240
 Why?
Neoplasms, Multiple Primary
1
2005
42
0.240
 Why?
Aged
14
2025
9741
0.230
 Why?
Paraproteinemias
2
2016
72
0.220
 Why?
Aged, 80 and over
8
2017
3226
0.220
 Why?
Pheochromocytoma
1
2023
36
0.220
 Why?
Adrenal Gland Neoplasms
1
2023
51
0.210
 Why?
Proteasome Endopeptidase Complex
1
2024
116
0.210
 Why?
Dermatofibrosarcoma
1
2003
8
0.210
 Why?
Oncogene Proteins, Fusion
1
2003
57
0.210
 Why?
Kidney Transplantation
1
2024
189
0.190
 Why?
Kidney Diseases, Cystic
1
2021
19
0.180
 Why?
Immunoglobulin G
2
2014
190
0.180
 Why?
Multiple Myeloma
3
2017
2998
0.180
 Why?
Precancerous Conditions
1
2021
82
0.180
 Why?
Carcinoma, Transitional Cell
2
2012
51
0.170
 Why?
Qb-SNARE Proteins
1
2019
6
0.170
 Why?
Qc-SNARE Proteins
1
2019
10
0.170
 Why?
Actin Cytoskeleton
1
2019
21
0.170
 Why?
Hepatic Stellate Cells
1
2019
17
0.170
 Why?
Antineoplastic Agents
3
2017
1172
0.170
 Why?
Neoplasms, Plasma Cell
1
2020
36
0.170
 Why?
Myofibroblasts
1
2019
49
0.160
 Why?
Retrospective Studies
6
2025
6263
0.160
 Why?
Kidney Failure, Chronic
1
2021
201
0.160
 Why?
Cell Nucleus
2
2010
182
0.160
 Why?
Neoplasm Metastasis
2
2010
232
0.160
 Why?
Mice
12
2025
5687
0.150
 Why?
Myoblasts
1
2018
18
0.150
 Why?
Melanoma
2
2018
280
0.140
 Why?
Animals
15
2025
13124
0.140
 Why?
Synovitis
1
2017
21
0.140
 Why?
Capillaries
4
2014
52
0.140
 Why?
Eosinophilia
1
2017
35
0.140
 Why?
Cell Proliferation
1
2021
985
0.140
 Why?
DNA, Neoplasm
3
2008
143
0.140
 Why?
Angiomyolipoma
1
2016
10
0.130
 Why?
Thoracic Neoplasms
1
2016
13
0.130
 Why?
Tuberous Sclerosis
1
2016
36
0.130
 Why?
Tumor Suppressor Proteins
1
2016
128
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2017
226
0.120
 Why?
Receptors, Lysosphingolipid
1
2014
5
0.120
 Why?
Reactive Nitrogen Species
3
2011
23
0.120
 Why?
Urothelium
1
2014
17
0.120
 Why?
Hemangiosarcoma
1
2014
15
0.120
 Why?
Mice, Inbred C57BL
6
2025
1808
0.120
 Why?
Neoplasm Staging
3
2014
746
0.110
 Why?
Immunoglobulin kappa-Chains
1
2014
20
0.110
 Why?
Necrosis
2
2012
174
0.110
 Why?
Glomerulonephritis, Membranous
1
2014
27
0.110
 Why?
Rolipram
1
2013
2
0.110
 Why?
Phosphodiesterase 4 Inhibitors
1
2013
4
0.110
 Why?
Molecular Targeted Therapy
1
2014
123
0.110
 Why?
Microscopy, Electron
2
2020
77
0.110
 Why?
Glomerular Filtration Rate
4
2017
119
0.110
 Why?
Translocation, Genetic
2
2005
240
0.110
 Why?
Organ Preservation
2
2024
30
0.100
 Why?
Sarcoidosis
1
2013
44
0.100
 Why?
Prospective Studies
2
2010
2378
0.100
 Why?
Livedo Reticularis
1
2012
5
0.100
 Why?
Cryoglobulinemia
1
2012
13
0.100
 Why?
Lipoprotein Lipase
1
2012
13
0.100
 Why?
DNA, Mitochondrial
2
2003
111
0.100
 Why?
Metalloporphyrins
1
2011
6
0.100
 Why?
Free Radical Scavengers
1
2011
25
0.100
 Why?
Cellular Microenvironment
1
2011
27
0.090
 Why?
Adrenal Cortex Neoplasms
1
2011
6
0.090
 Why?
Myocardium
2
2017
445
0.090
 Why?
Polymerase Chain Reaction
3
2008
449
0.090
 Why?
Triglycerides
1
2012
160
0.090
 Why?
Stilbenes
1
2011
52
0.090
 Why?
Tissue Array Analysis
2
2011
45
0.090
 Why?
Microscopy, Fluorescence
2
2014
158
0.090
 Why?
Peritoneal Neoplasms
1
2012
63
0.090
 Why?
Disease Models, Animal
4
2025
1436
0.090
 Why?
Metalloendopeptidases
1
2011
69
0.090
 Why?
Hematuria
1
2010
26
0.090
 Why?
Fluorescent Antibody Technique
1
2010
104
0.090
 Why?
Ejaculatory Ducts
1
2010
3
0.090
 Why?
Plasma Cells
1
2012
221
0.090
 Why?
Seminal Vesicles
1
2010
13
0.090
 Why?
RNA, Messenger
4
2012
1089
0.080
 Why?
Hemodynamics
1
2011
265
0.080
 Why?
In Situ Hybridization
2
2006
66
0.080
 Why?
Antioxidants
1
2011
239
0.080
 Why?
Prostate
1
2010
114
0.080
 Why?
Epithelial Cells
2
2011
207
0.080
 Why?
Lymphatic Metastasis
1
2010
222
0.080
 Why?
Fatal Outcome
1
2009
197
0.080
 Why?
Survival Analysis
3
2017
661
0.080
 Why?
Iron Chelating Agents
1
2008
11
0.080
 Why?
Ligation
3
2014
62
0.080
 Why?
Nephritis, Interstitial
1
2008
9
0.080
 Why?
Benzoates
1
2008
21
0.080
 Why?
Microsatellite Repeats
1
2008
37
0.080
 Why?
Glomerular Mesangium
1
2008
7
0.070
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
 Why?
Loss of Heterozygosity
1
2008
75
0.070
 Why?
Basement Membrane
1
2008
16
0.070
 Why?
Triazoles
1
2008
113
0.070
 Why?
Cell Membrane
1
2008
246
0.070
 Why?
Disease Progression
2
2025
829
0.070
 Why?
Glomerular Basement Membrane
1
2007
10
0.070
 Why?
Mutation
2
2003
1280
0.070
 Why?
Oxidative Stress
1
2011
772
0.070
 Why?
Kidney Pelvis
1
2006
17
0.070
 Why?
Prednisone
1
2007
101
0.070
 Why?
Paraffin Embedding
1
2006
51
0.070
 Why?
Karyotyping
3
2017
65
0.070
 Why?
Prognosis
2
2025
1978
0.070
 Why?
Heart Diseases
1
2009
214
0.070
 Why?
Young Adult
4
2021
4102
0.070
 Why?
Nephrotic Syndrome
1
2006
18
0.060
 Why?
Mice, Knockout
2
2025
844
0.060
 Why?
Clofibric Acid
1
2005
6
0.060
 Why?
Chromosomes, Human, Pair 2
1
2005
21
0.060
 Why?
Chromosomes, Human, Pair 7
1
2005
29
0.060
 Why?
Lipopolysaccharides
1
2006
197
0.060
 Why?
Anti-Bacterial Agents
1
2011
745
0.060
 Why?
Chromosomes, Human, Pair 9
1
2005
13
0.060
 Why?
Chromosomes, Human, Pair 5
1
2005
15
0.060
 Why?
Neurofibroma
1
2005
16
0.060
 Why?
Glucocorticoids
1
2007
230
0.060
 Why?
Fibroma
1
2005
37
0.060
 Why?
Foot
1
2005
40
0.060
 Why?
Blood Pressure
3
2011
531
0.060
 Why?
Protein Synthesis Inhibitors
1
2004
17
0.060
 Why?
Biopsy, Needle
1
2005
178
0.060
 Why?
Endodeoxyribonucleases
1
2004
44
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
121
0.060
 Why?
Adrenalectomy
1
2023
35
0.060
 Why?
Adrenal Glands
1
2023
40
0.050
 Why?
Vulva
1
2003
17
0.050
 Why?
Groin
1
2003
16
0.050
 Why?
Gene Expression Regulation, Enzymologic
1
2004
179
0.050
 Why?
RNA, Neoplasm
1
2003
43
0.050
 Why?
Proteasome Inhibitors
1
2024
104
0.050
 Why?
Time Factors
3
2014
2935
0.050
 Why?
Micromanipulation
1
2002
2
0.050
 Why?
Cytoplasm
1
2003
89
0.050
 Why?
Immunoenzyme Techniques
1
2003
137
0.050
 Why?
Biopsy, Fine-Needle
1
2003
108
0.050
 Why?
Blotting, Western
3
2012
578
0.050
 Why?
Perfusion
1
2002
49
0.050
 Why?
Rats
2
2024
3292
0.050
 Why?
Sodium Chloride
1
2002
55
0.050
 Why?
Neoplasm Invasiveness
2
2014
269
0.050
 Why?
Blood Flow Velocity
2
2013
99
0.050
 Why?
Sequence Analysis, DNA
1
2003
226
0.050
 Why?
Hypothermia, Induced
1
2002
39
0.050
 Why?
Mass Screening
1
2005
344
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
572
0.050
 Why?
Cardiac Surgical Procedures
1
2025
313
0.050
 Why?
Severity of Illness Index
1
2025
978
0.050
 Why?
Capillary Permeability
2
2011
34
0.050
 Why?
Adolescent
3
2014
6443
0.050
 Why?
Bone Neoplasms
1
2003
179
0.050
 Why?
Hyperplasia
1
2021
96
0.050
 Why?
Transcription Factors
1
2004
565
0.040
 Why?
Cell Differentiation
2
2014
640
0.040
 Why?
Liver
2
2019
1132
0.040
 Why?
Clinical Laboratory Techniques
1
2020
28
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2021
231
0.040
 Why?
Heart Rate
2
2011
307
0.040
 Why?
Stress Fibers
1
2019
5
0.040
 Why?
Actin Depolymerizing Factors
1
2019
5
0.040
 Why?
rho-Associated Kinases
1
2019
20
0.040
 Why?
RNA, Viral
1
2020
107
0.040
 Why?
Carbon Tetrachloride
1
2019
22
0.040
 Why?
Treatment Outcome
3
2017
5283
0.040
 Why?
Gene Knockdown Techniques
1
2019
105
0.040
 Why?
Cell Separation
1
2019
92
0.040
 Why?
Child, Preschool
2
2011
3942
0.040
 Why?
Nitrites
2
2011
32
0.040
 Why?
Nitrates
2
2011
30
0.040
 Why?
Liver Neoplasms
1
2003
326
0.040
 Why?
Actins
1
2019
114
0.040
 Why?
Neutrophil Infiltration
2
2012
25
0.040
 Why?
Antibodies, Monoclonal
1
2003
462
0.040
 Why?
RNA Interference
1
2019
178
0.040
 Why?
RNA, Small Interfering
1
2019
208
0.040
 Why?
Cecum
2
2011
60
0.040
 Why?
Cell Movement
1
2019
247
0.040
 Why?
Wound Healing
1
2019
186
0.040
 Why?
Cell Dedifferentiation
1
2018
9
0.040
 Why?
Reactive Oxygen Species
2
2011
409
0.040
 Why?
Kidney Function Tests
1
2017
51
0.040
 Why?
Lung Neoplasms
1
2003
601
0.030
 Why?
Liver Cirrhosis
1
2019
229
0.030
 Why?
Microscopy, Video
2
2007
13
0.030
 Why?
Cell Line
1
2019
988
0.030
 Why?
Nitric Oxide Synthase Type II
2
2007
65
0.030
 Why?
Acute Disease
2
2008
373
0.030
 Why?
Cardiomyopathy, Restrictive
1
2016
5
0.030
 Why?
Risk Factors
1
2005
3724
0.030
 Why?
Cysts
1
2016
51
0.030
 Why?
Genomics
1
2017
279
0.030
 Why?
Bone Marrow
1
2017
363
0.030
 Why?
Immunotherapy
1
2017
235
0.030
 Why?
Oxadiazoles
1
2014
10
0.030
 Why?
Permeability
1
2014
67
0.030
 Why?
Punctures
1
2014
52
0.030
 Why?
Thiophenes
1
2014
36
0.030
 Why?
Antigen-Antibody Complex
1
2014
35
0.030
 Why?
Terminology as Topic
1
2014
67
0.030
 Why?
Pyrazoles
1
2014
111
0.030
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
74
0.030
 Why?
Pyridines
1
2014
131
0.030
 Why?
Granuloma
1
2013
45
0.030
 Why?
Signal Transduction
1
2019
1624
0.030
 Why?
Bone Marrow Examination
1
2012
11
0.030
 Why?
Receptors, Lipoprotein
1
2012
7
0.030
 Why?
Azo Compounds
1
2012
10
0.030
 Why?
Angiopoietins
1
2012
5
0.030
 Why?
Peroxisome Proliferator-Activated Receptors
1
2012
14
0.030
 Why?
Plasma Exchange
1
2012
25
0.020
 Why?
Immunosuppressive Agents
1
2014
225
0.020
 Why?
Coloring Agents
1
2012
66
0.020
 Why?
Adipose Tissue, White
1
2012
34
0.020
 Why?
Epithelium
1
2011
66
0.020
 Why?
Cystectomy
1
2012
49
0.020
 Why?
Cell Hypoxia
1
2011
82
0.020
 Why?
Child
2
2016
6906
0.020
 Why?
Superoxide Dismutase
1
2011
116
0.020
 Why?
Telemetry
1
2011
29
0.020
 Why?
Peritonitis
1
2011
25
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1372
0.020
 Why?
Multiple Organ Failure
1
2011
48
0.020
 Why?
Vasodilator Agents
1
2011
100
0.020
 Why?
Hydroxamic Acids
1
2011
37
0.020
 Why?
Hypothermia
1
2011
36
0.020
 Why?
Fluid Therapy
1
2011
75
0.020
 Why?
Oxidation-Reduction
1
2011
316
0.020
 Why?
Interleukin-1beta
1
2011
72
0.020
 Why?
United States
1
2021
4955
0.020
 Why?
Body Weight
1
2012
517
0.020
 Why?
Animals, Newborn
1
2011
363
0.020
 Why?
Membrane Proteins
1
2012
332
0.020
 Why?
Gene Expression
1
2012
610
0.020
 Why?
Skin
1
2012
388
0.020
 Why?
Infant, Newborn
1
2016
2749
0.020
 Why?
Iron Overload
1
2008
8
0.020
 Why?
Cells, Cultured
1
2012
1571
0.020
 Why?
Erythrocyte Transfusion
1
2008
52
0.020
 Why?
Eosinophils
1
2008
40
0.020
 Why?
Drug Hypersensitivity
1
2008
38
0.020
 Why?
Myelodysplastic Syndromes
1
2008
78
0.020
 Why?
Rats, Sprague-Dawley
1
2011
1585
0.020
 Why?
NADP
1
2006
22
0.020
 Why?
Blood Urea Nitrogen
1
2006
39
0.020
 Why?
Lysine
1
2007
84
0.020
 Why?
Creatinine
1
2006
145
0.020
 Why?
Nuclease Protection Assays
1
2005
2
0.020
 Why?
Receptors, CCR5
1
2005
6
0.020
 Why?
Stress, Physiological
1
2006
171
0.020
 Why?
Receptors, CCR1
1
2005
10
0.020
 Why?
Chemokine CCL5
1
2005
9
0.020
 Why?
Receptors, Chemokine
1
2005
13
0.020
 Why?
Nitric Oxide
1
2007
259
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2005
37
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2005
72
0.020
 Why?
Intercellular Adhesion Molecule-1
1
2005
62
0.020
 Why?
Muscle Neoplasms
1
2005
16
0.010
 Why?
Chemokines
1
2005
75
0.010
 Why?
PPAR alpha
1
2005
56
0.010
 Why?
Enzyme Inhibitors
1
2007
377
0.010
 Why?
Prostatectomy
1
2005
82
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2005
234
0.010
 Why?
Chromosome Mapping
1
2005
153
0.010
 Why?
Kidney Tubules, Proximal
1
2004
62
0.010
 Why?
Receptors, Cytoplasmic and Nuclear
1
2004
68
0.010
 Why?
Ligands
1
2004
203
0.010
 Why?
Cell Death
1
2004
175
0.010
 Why?
Pyrimidines
1
2005
191
0.010
 Why?
Antigens, CD
1
2005
222
0.010
 Why?
NF-kappa B
1
2005
315
0.010
 Why?
Tumor Necrosis Factor-alpha
1
2005
393
0.010
 Why?
Models, Genetic
1
2003
172
0.010
 Why?
Multigene Family
1
2002
54
0.010
 Why?
Infant
1
2011
3628
0.010
 Why?
Renal Artery Obstruction
1
2002
22
0.010
 Why?
Lasers
1
2002
106
0.010
 Why?
Base Sequence
1
2003
639
0.010
 Why?
Polymorphism, Genetic
1
2002
180
0.010
 Why?
Cytokines
1
2005
606
0.010
 Why?
Models, Animal
1
2002
227
0.010
 Why?
Ischemia
1
2002
153
0.010
 Why?
Swine
1
2002
408
0.010
 Why?
Feasibility Studies
1
2002
390
0.010
 Why?
Laparoscopy
1
2002
173
0.010
 Why?
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (349) concept(s)
_
Co-Authors Expand Description
See all (45) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department